Ammonia Inhalants

Quick links

Choose a section

Quick links to important sections

Advertisements

Ammonia Inhalants

Selected form

Advertisements
Advertisements

Treatment option: Skin Disinfection, Syncope

Advertisements

Overview of Ammonia Inhalants

Property Description
Active Ingredient Ammonium Carbonate ((NH4)2CO3) or Ammonium Chloride (NH4Cl)
Form Solution or Inhalant Capsule
Pharmacological Class Respiratory Stimulant
Common Use Restoring alertness after fainting (syncope)
Origin Inorganic compound (Chemically derived)

What are Ammonia Inhalants and their Pharmacological Class?

Ammonia Inhalants, frequently known by the common name Smelling Salts, are a type of non-prescription pharmaceutical product formally classified as a Respiratory Stimulant. This product is fundamentally an inorganic compound formulation designed to elicit an immediate, protective physiological reflex when inhaled. Smelling salts are utilized as a respiratory stimulant to counteract faintness. The efficacy of this class is clinically recognized for its ability to produce rapid physiological arousal, a feature critical in emergency and athletic first-aid scenarios. The primary general purpose of this classification is to provide an instantaneous, non-invasive method for inducing arousal and restoring alertness.


What is the Composition and Form of Smelling Salts?

The preparation's efficacy relies on the rapid release of volatile ammonia (NH3) gas via the Inhalation route. The actual active ingredient that generates the ammonia is typically the solid salt Ammonium Carbonate or, less commonly, Ammonium Chloride. Ammonium Carbonate is the primary source of the ammonia vapor used in aromatic spirits preparations. The preparation is a Combination Product formulated as a liquid Solution, sometimes referred to as Aromatic Spirits, contained within a crushable unit like an Inhalant Capsule or Ampule. These liquid formulations use Alcohol (Ethanol) and Water (H2O) as a vehicle, making them a distinctive volatile irritant preparation.


What is the General Purpose of a Respiratory Stimulant?

The singular, immediate goal of using Ammonia Inhalants as a Respiratory Stimulant is to cause immediate, involuntary arousal and restore consciousness by triggering the inhalation reflex. The strong, pungent odor causes an abrupt sensory shock that dramatically increases the rate and depth of breathing, which serves to quickly provide oxygen to the brain. This restorative action is intended to interrupt or prevent the temporary loss of consciousness associated with circulatory changes, commonly known as fainting (syncope).

Regulatory References

  1. BARDOWN SMELLING SALTS- ammonia inhalant liquid - DailyMed
  2. SMELLING SALTS- ammonia powder - DailyMed
Advertisements

What side effects are possible with Ammonia Inhalants?

Possible Side Effects and Safety Information

Ammonia inhalants have a safety profile defined by the chemical's corrosive and irritant properties, with a number of local and systemic adverse reactions reported. The official safety documentation emphasizes restrictions and contraindications, particularly concerning pre-existing conditions and contact with sensitive tissues.

Adverse Reaction Scope

Adverse Reaction Category Examples of Documented Effects
Local and Corrosive Effects Chemical burns to the eyes and skin; irritation of the nasal, throat, and respiratory membranes; temporary vision impairment or, in severe cases, permanent blindness.
Respiratory System Coughing; difficulty breathing; shortness of breath; airway constriction; exacerbation of conditions such as asthma, bronchitis, or emphysema. Prolonged inhalation may result in permanent lung damage.
Systemic/Serious Reactions Headache; vomiting; diarrhea; fainting (syncope); seizures (convulsions); and, rarely, coma or death (associated with misuse or excessive exposure).
Neurological Effects Loss of consciousness (stupor); confusion; dizziness; or lack of coordination.

Safety-Related Restrictions

The product is Contraindicated for use in individuals with chronic pulmonary conditions, including asthma, bronchitis, or emphysema, due to the inherent risk of severe respiratory irritation. Safe use requires keeping the product away from the eyes and any broken or irritated skin to prevent chemical burns. Official labeling restricts the product to a single, brief inhalation to mitigate the risks associated with excessive exposure. Adverse reactions involving the eyes, difficulty breathing, or seizures require immediate medical attention.

Regulatory Summary

The safety profile is officially structured around the hazard classification of ammonia as a severe irritant. Adverse events are often dose- or exposure-related, with excessive use associated with increased risk of systemic toxicity and severe local injury. The product's intended use is limited to inhalation only, and its safety relies on strict adherence to the brief inhalation method to avoid clinically significant harm.

Advertisements

Overdose and Emergency Response

The official regulatory profile for Ammonia Inhalants focuses on risks associated with accidental ingestion or direct corrosive exposure to the liquid solution, rather than conventional excessive use. Accidental swallowing of the liquid formulation is formally classified in official labeling as poisoning, which mandates seeking immediate medical help or contacting a Poison Control Center immediately.

The most severe consequences are associated with direct liquid contact. Regulatory warnings document the potential for severe eye burns, which may lead to permanent vision loss. If contact with the eyes occurs, the explicit emergency action requires rinsing the eyes thoroughly with water for 15 minutes and immediately contacting a doctor or emergency room. For skin contact, the procedural steps include removing contaminated clothing and rinsing the affected area with large amounts of water.

Symptoms of overexposure to the vapor are documented as nasal irritation, coughing, or shortness of breath. If these irritative symptoms persist, or if the individual is non-responsive after use, the official label requires discontinuing use and asking a doctor. No specific therapeutic antidote is detailed in the regulatory prescribing information.

Advertisements

Therapeutic Uses of Ammonia Inhalants

What Ammonia Inhalants Treat: Main Uses and Benefits

Ammonia Inhalants are commonly used in first-aid scenarios to address the acute symptoms of fainting (syncope), which involves a temporary loss of consciousness due to brief circulatory changes. The official therapeutic use is relevant for addressing or managing faintness. This product provides support for maintaining or regaining a sense of alertness and consciousness, which may assist in addressing the episode when symptoms are acute.

The inhalant is applied when patients experience the acute pre-syncopal state, marked by dizziness, lightheadedness, and the sensation of feeling faint. By intervening at this stage, the inhalant offers supportive therapeutic benefit that contributes to easing symptoms related to systemic imbalance and may help with maintaining functional stability.

Beyond medical first-aid, this inhalant is commonly employed in athletic and high-demand contexts to induce a non-sustained surge of heightened focus and arousal. This provides temporary support that eases symptoms related to neurological activity, which may support general well-being during symptomatic periods.


Quick Fact: Relief for Transient Loss of Consciousness

The core benefit of the inhalant is providing supportive therapeutic benefit that contributes to easing symptoms related to systemic imbalance, thus helping patients cope more steadily with difficult episodes.

Regulatory References

  1. NIH DailyMed product label
Advertisements

Eligibility and Restrictions for Use

Ammonia Inhalants, commonly known as smelling salts, are subject to specific eligibility rules defined by regulatory bodies to ensure appropriate use. The official profile is primarily defined by contraindications for individuals with pre-existing conditions and clear age-based restrictions.

Eligibility Status Specific Regulatory Statement
Contraindicated Individuals with breathing problems such as asthma or emphysema, or chronic lung disease, must not use this medicine.
Use is prohibited in children under 2 years of age on some regulatory labels.
Restricted Use Children under 12 years of age should only use the medicine after consulting a doctor ("ask a doctor").
Use must be stopped, and medical attention sought, if the patient is non-responsive or if the fainting condition persists.
Conditional Prohibition Some product labels prohibit use for individuals who are pregnant or nursing, placing them in a non-eligible category.

Adults and adolescents 12 years of age and older are eligible for use under standard labeled directions. The regulatory documents emphasize that the product is for external inhalation only. The eligibility criteria prioritize safety by excluding populations with compromised respiratory or cardiovascular function, as documented in official prescribing information.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Ammonia Inhalants is characterized by the absence of documented systemic drug interactions. This is consistent with the product's classification as a Respiratory Stimulant that functions through the rapid, local irritation of nasal and pulmonary membranes, thereby initiating a physiological reflex. Due to this non-systemic and transient action, the product does not typically interact with metabolic pathways or circulation in the manner of orally administered or long-acting drugs.


Official Interaction Profile Summary

Interaction Category Official Regulatory Statement
Pharmacokinetic Interactions No documented interactions involving metabolic enzymes (e.g., CYP450) or drug transporters are listed in government labeling.
Pharmacodynamic Interactions Regulatory documents do not contain statements about additive, synergistic, or antagonistic effects with other medicinal products.
Co-administration Restrictions No formal list of contraindicated combinations with other specific medicines is documented.
Timing or Separation Rules No mandatory timing or separation requirements are specified for co-administration with other drugs, food, alcohol, or herbal products.

Official government regulatory documents define the product's interaction structure primarily by the lack of documented systemic interaction concerns. This means that labeling provides no formal classification of interaction severity, nor does it list specific medicines that require dose adjustment or prohibited combinations based on pharmacokinetic or pharmacodynamic risk.

Advertisements

Mechanism of Action

Ammonia vapor functions as an acute respiratory reflex stimulant through its local interaction with the mucous membranes of the nasal passages and upper respiratory tract. This localized interaction results in the non-specific chemical irritation of chemosensitive nerve endings. Specifically, the stimulation targets the terminal fibers of the trigeminal nerve (V1 ophthalmic branch and V2 maxillary branch) and, to a lesser extent, the glossopharyngeal nerve (IX).

The immediate afferent neural impulse ascends from the nasal cavity to the brainstem. This signal initiates a reflexive medullary cascade within the respiratory and vasomotor centers. The consequence is an involuntary, rapid increase in the rate and depth of respiration (hyperpnea), resulting from the central nervous system modulation of pulmonary activity. This mechanistic sequence does not involve systemic absorption or direct action on the cardiovascular system.

Advertisements

Dosage and Administration Information

Administration Guidelines for Ammonia Inhalants

Ammonia Inhalants are strictly administered via the Respiratory (Inhalation) route, and the product is designated for External Use Only. The use is restricted to a single, acute event and is applied as needed (PRN).

The standard dosage for an event is one single unit dose, typically a crushed ampule or packet containing Ammonia 15%. Dosage limits may include not using the product more than once every 60 minutes or more than 10 times per day.

Feature Instruction
Dosing Unit One crushed ampule or packet
Frequency Used as needed for a single acute event
Age Group Adults and children 12 years of age and older

Procedural Steps for Administration

Proper use involves specific steps to control the delivery of the ammonia vapor:

  1. Preparation: Hold the inhalant unit away from the face and then crush the ampule or packet between the thumb and forefinger to release the vapor.
  2. Administration: Position the crushed unit or bottle approximately 10–15 cm (4–6 inches) from the patient’s nostrils.
  3. Approach: The product is to be gradually moved closer until the patient revives. The administration should stop immediately once the patient is revived or if the condition persists.
Advertisements

Recent Clinical Evidence

Ammonia Inhalants: Recent Clinical Evidence

Ammonia inhalants, commonly known as smelling salts, are used to arouse consciousness in individuals who have fainted. When inhaled, the ammonia gas irritates the mucous membranes of the nose and lungs, triggering an involuntary inhalation reflex. This reflex causes the person to breathe rapidly and deeply, which can lead to increased heart rate and a temporary elevation of blood flow to the brain, helping to restore alertness.


Approved Use and Regulatory Status

The primary approved use for ammonia aromatic preparations in the United States is as a reflex stimulant to prevent or treat fainting (syncope). The use of these products for other purposes, such as enhancing athletic performance, has not been approved. The U.S. Food and Drug Administration (FDA) has issued warnings regarding unapproved ammonia-based inhalants marketed with claims of boosting energy and alertness, noting that the products have not been demonstrated to be safe or effective for those intended uses.


Research Findings on Ergogenic Use

Despite widespread use by athletes in sports like powerlifting and football, scientific research on the performance-enhancing effects of ammonia inhalants remains limited and mixed.

Area of Research Key Findings from Studies
Maximal Strength/Power Most studies have found no significant change in maximal strength or power output (e.g., 1-repetition maximum) compared to placebo.
Explosive Force Some research suggests a temporary increase in the rate of force development (explosive force), which may be attributed to a psychological stimulation effect.
Concussion Risk Medical bodies strongly advise against use following head trauma, as the arousal effect may temporarily mask symptoms, leading to a delay in diagnosis and treatment.
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Ammonia Inhalants (FAQ)

Q: Is the 'jolt' or alertness felt from smelling salts a physiological energy boost or a temporary reflex?

The effect is not a physiological energy boost. Official information indicates the product works as a reflexive respiratory stimulant, which means it irritates the nerves in the nose to trigger an involuntary increase in the rate and depth of breathing. This action is local and transient, and does not involve systemic absorption or direct action on the body's circulation.

Q: How quickly do the effects of the ammonia vapor start and stop?

Ammonia inhalants are designed for an immediate and rapid effect to cause arousal. The product’s official administration guidelines state that use is discontinued immediately once the patient is revived. This indicates that the effect is intended to be transient and short-lived, serving only to cause immediate alertness.

Q: Does inhaling ammonia increase the flow of oxygen to the brain?

The strong inhalation reflex is intended to help restore consciousness by causing rapid and deep breathing (hyperpnea). This action can quickly provide oxygen to the brain and is associated with a temporary elevation of blood flow to the head. This restorative action is intended to interrupt the temporary loss of consciousness related to fainting.

Q: Can frequent use of smelling salts cause a decreased sense of smell (olfactory fatigue)?

Yes, prolonged exposure to ammonia can cause olfactory fatigue, a temporary decrease in the sense of smell. Official health guidance indicates that the chemical nature of ammonia can make its presence difficult to detect after continuous exposure. Long-term, repeated use has also been associated with permanent loss of smell and taste.

Q: What are the potential long-term risks associated with using ammonia inhalants regularly?

Regular or frequent misuse of ammonia inhalants carries several potential long-term risks. These risks include the potential for permanent lung damage and chronic respiratory irritation due to the chemical's corrosive properties. Prolonged exposure has also been linked to reports of neural damage or loss of sense of smell and taste.

Q: What should be done immediately if the ammonia liquid contacts the skin or eyes?

If the ammonia liquid contacts the eyes, official labeling advises immediate irrigation with large amounts of water for at least 15 minutes. If it contacts the skin, promptly wash the contaminated area with soap and water. Medical attention is advised immediately for eye contact or if any irritation persists.

Q: Does scientific evidence support the idea that smelling salts enhance athletic performance or strength?

No, studies and official information do not support the idea that smelling salts enhance athletic performance or strength. Most scientific evidence has found no significant change in maximal strength compared to placebo. The FDA has warned that these products are not demonstrated to be safe or effective for performance enhancement.

Q: Is using ammonia inhalants to increase energy or focus considered an 'off-label' use?

Yes, using the product to increase energy or focus is considered an unapproved use. The only function approved by regulatory bodies is to help prevent or treat fainting. Official warnings have been issued regarding products that are marketed with claims of boosting energy or alertness.

Q: Are there any age restrictions on the sale or purchase of ammonia inhalants?

Ammonia Inhalants are generally classified as an Over-the-Counter (OTC) drug product, meaning they can be purchased without a prescription. However, regulatory guidelines place medical restrictions on use by age. Use is medically restricted to adults and children 12 years of age and older under standard directions.

Q: Are there reports of severe adverse events linked to the misuse of these products?

Yes, severe adverse events have been reported in cases of misuse or excessive exposure. Reports include symptoms such as shortness of breath, seizures, vomiting, and migraines. Furthermore, severe reactions like coma or death have been associated with extreme misuse of these inhalants.

Q: Is the sensation of a burning nose a normal part of the mechanism of action?

The chemical's mechanism of action relies on local irritation to the nasal membranes to trigger the arousal reflex. Due to this intended action, users may commonly experience a strong irritating or burning sensation in the nose, eyes, and throat.

Q: Can Ammonia Inhalants be used to treat simple dizziness or just a full faint?

The official approved use for the inhalant is to prevent or treat the full temporary loss of consciousness, known as fainting or syncope. While dizziness may precede fainting, the product is primarily intended as a reflex stimulant to restore alertness after a syncopal episode.

Q: Can the product lose its potency if the container is not sealed properly?

Yes. Regulatory storage requirements indicate that the product should be kept tightly closed immediately after each use. This requirement is important because the product's potency relies on containing the volatile ammonia vapor. Failure to seal the container properly can result in a loss of effectiveness over time.

Q: Why did the NFL ban the use of smelling salts for its players?

The National Football League (NFL) prohibited clubs from providing smelling salts primarily due to health and safety concerns. The league determined that the product's arousal effect could potentially mask symptoms of a serious head injury, such as a concussion, which could then delay accurate medical diagnosis.

Q: Are Ammonia Inhalants considered a banned or prohibited substance by the World Anti-Doping Agency (WADA)?

No. According to the current official documentation, Ammonia Inhalants are not listed as a prohibited substance on the World Anti-Doping Agency (WADA) Prohibited List. This means their use is not currently restricted in competitive sports governed by WADA rules.

Q: What is the legal classification of Ammonia Inhalants (e.g., prescription-only or over-the-counter)?

Ammonia Inhalants are classified by regulatory bodies as an Over-the-Counter (OTC) drug product. This legal classification means the product is available for purchase without requiring a doctor's prescription for its approved use in treating fainting.

Q: Why do some commercial smelling salts contain perfumes or essential oils?

Some commercial formulations include inactive ingredients such as lavender oil, lemon oil, or peppermint oil. Regulatory documents list these substances as flavoring agents or perfumes. These are added to the product but do not contribute to its primary function as a respiratory stimulant.

Q: What happens if a small amount of the liquid from an inhalant ampule is accidentally swallowed?

The product is strictly for external use only. Official warnings indicate that if the liquid is swallowed, the user must immediately seek medical help or contact a Poison Control Center. Warnings state that attempting to induce vomiting is not advised.

Q: Is there a risk of becoming dependent on ammonia inhalants for energy or wakefulness?

While official regulatory labels do not explicitly address dependence, the product's non-approved use for energy and alertness may involve patterns that align with the criteria for Inhalant Use Disorder. This pattern of misuse includes compulsive use and psychological dependence on the inhalant's effect.

Advertisements

How should Ammonia Inhalants be stored and disposed of?

How to Store and Dispose of Ammonia Inhalants

Ammonia inhalants must be stored strictly according to the conditions defined in official regulatory labeling to ensure product stability and safety.

Storage Requirements

  • Temperature: Store at controlled room temperature, which is 20 C to 25 C (68 F to 77 F). Excursions are permitted between 15 C and 30 C.
  • Protection: The product must be protected from light and kept tightly closed in its original container.
  • Flammability: Due to its composition, the inhalant must be stored away from all sources of ignition, heat, and flame.
  • Child Safety: It is mandatory to keep this product out of reach of children.

Disposal

Expired or unused inhalants must be disposed of in a manner consistent with local regulations for pharmaceutical waste. Individuals should consult a pharmacist or local waste disposal company for guidance on proper handling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ammonia Inhalants found in:

A-Z Index: